Reumatoloxía

2014

1. 2-(dimethylamino)ethyl methacrylate/(2-hydroxyethyl) methacrylate/α-tricalcium phosphate cryogels for bone repair, preparation and evaluation of the biological response of human trabecular bone-derived cells and mesenchymal stem cells

   Polymers, Vol. 6, Núm. 10, pp. 2510-2525

2. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

   Arthritis Research and Therapy, Vol. 16, Núm. 1

3. A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip

   Annals of the Rheumatic Diseases, Vol. 73, Núm. 12, pp. 2130-2136

4. A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine

   Scientific Reports, Vol. 4

5. Abatacept therapy in rheumatoid arthritis with interstitial lung disease

   Journal of Clinical Rheumatology, Vol. 20, Núm. 8, pp. 445-446

6. Adipokines as drug targets in joint and bone disease

   Drug Discovery Today, Vol. 19, Núm. 3, pp. 241-258

7. Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis

   BioMed Research International, Vol. 2014

8. Adipokines, metabolic syndrome and rheumatic diseases

   Journal of Immunology Research, Vol. 2014

9. Adiponectin and leptin: New targets in inflammation

   Basic and Clinical Pharmacology and Toxicology, Vol. 114, Núm. 1, pp. 97-102

10. Algoritmos prácticos de decisión en artrosis de rodilla

    IMC

11. An update on leptin as immunomodulator

    Expert Review of Clinical Immunology, Vol. 10, Núm. 9, pp. 1165-1170

12. Analysis of autoantibody profiles in osteoarthritis using comprehensive protein array concepts

    Journal of Proteome Research, Vol. 13, Núm. 11, pp. 5218-5229

13. Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis

    Arthritis and Rheumatology, Vol. 66, Núm. 11, pp. 2924-2937

14. Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82

15. Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

    Annals of the Rheumatic Diseases

16. Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies

    Arthritis and Rheumatology, Vol. 66, Núm. 4, pp. 940-949

17. Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

    Pharmacogenetics and Genomics, Vol. 24, Núm. 5, pp. 238-245

18. BIOBADASER, BIOBADAMERICA, and BIOBADADERM: Safety registers sharing commonalities across diseases and countries

    Clinical and Experimental Rheumatology, Vol. 32, pp. S163-S167

19. Basophils control T-cell responses and limit disease activity in experimental murine colitis

    Mucosal Immunology, Vol. 7, Núm. 1, pp. 188-199

20. Biochemical evidence for gap junctions and Cx43 expression in immortalized human chondrocyte cell line: A potential model in the study of cell communication in human chondrocytes

    Osteoarthritis and Cartilage, Vol. 22, Núm. 4, pp. 586-590